Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Clinical trial NCT05604170 · TERMINATED

Trial details

NCT number: NCT05604170
Sponsor: Marinus Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex

Start date: 2022-05-16
Primary completion: 2025-04-02
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.